Carlyle Group LP is lining up a USD 3.7 billion debt financing for the purchase of Ortho Clinical Diagnostics Inc, the diagnostics arm of Johnson & Johnson. Barclays Plc and Goldman Sachs Group Inc. are leading the deal, which includes USD 2.15 billion in term loans, USD 1.15 billion in bonds as well as a revolving credit of up to USD 400 million. The takeover was seen to be inked by the end of a week, unless delayed due to ongoing talks.